Albendazole in hydatid disease.
نویسندگان
چکیده
منابع مشابه
Albendazole in hydatid disease.
Valproic acid, or dipropylacetic acid, and its salt, sodium valproate, are used to treat a wide variety of seizure disorders. Until recently there was no convincing evidence demonstrating a teratogenic effect in humans. However, the association between other anticonvulsant drugs and congenital malformations has been recognized for more than a decade,I,2 and this, together witfI tbe lack of conv...
متن کاملTherapy of human hydatid disease with mebendazole and albendazole.
We report our experience in the treatment with benzoimidazole carbamates (mebendazole and albendazole) of 337 patients affected by hydatid cysts with different localizations. The treated cysts showed degenerative modifications in 50.6% of the cases after mebendazole treatment and in about 80% after albendazole treatment. Relapses after therapy were observed in 30% of the cases; about 95% of the...
متن کاملLiver hydatid disease: morphological changes of protoscoleces after albendazole therapy.
BACKGROUND Postoperative recurrence of the liver hydatid disease befalls approximately 10-30% of patients. Preoperative or postoperative therapy with albendazole in single therapeutic protocol (800 mg/d, within 28 days) indicated the need to evaluate the hydatid cyst liquid protoscoleces viability. Morphological changes of protoscoleces following the treatment with drugs are not well known. A...
متن کاملGamma knife radiosurgery and albendazole for cerebral alveolar hydatid disease.
Standard treatment of cerebral alveolar hydatid disease consists of open brain surgery and systemic albendazole. We describe a patient with inoperable cerebral alveolar hydatid cysts on whom gamma knife radiosurgery was used instead of open brain surgery. Because of the size of the multicystic lesion, the gamma knife procedure was done in two sessions. Repeated courses of albendazole were given...
متن کاملPenetration of albendazole sulphoxide into hydatid cysts.
The penetration of albendazole sulphoxide, the principal metabolite of albendazole into hydatid cysts (E granulosus) was measured by means of in vitro animal and clinical studies. The drug freely diffuses across the parasitic membranes. Cyst/serum concentrations of 22% were achieved in patients, longer pre-operative therapy produced higher concentrations.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1983
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.286.6359.103-a